| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3345 |
| Trial ID | NCT05741359 |
| Disease | B-Cell Non-Hodgkin's Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | BRL-201 |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | The Safety and Efficacy of BRL-201 in the Treatment of r/r B Lymphocyte Non-Hodgkin Lymphoma |
| Year | 2023 |
| Country | China |
| Company sponsor | Bioray Laboratories |
| Other ID(s) | 2022-BRL-201 |
| Cohort 1 | |||||||||
|
|||||||||